• View patient site
  • Order
Oncimmune
  • Our Company
    • About Oncimmune
    • Board of Directors
    • Scientific Board
    • Senior Leadership Team
    • Regulation & Quality
    • Press Releases
    • Events & News
  • Products
    • Lung Cancer Blood Test
    • Liver Cancer Blood Test
    • SeroTag® Platform
    • NavigAID
  • Resources
    • Industry Publications
    • Oncimmune Resources
    • Videos
  • Investors
    • Corporate Governance
    • Regulatory Newsflow
    • Share Price and Tools
    • Shareholder Analysis
    • Results, Reports & Presentations
    • Corporate Documents
    • Investor & Advisor Contacts
    • Aim Rule 26
  • Contact Us
  • Our Company
    • About Oncimmune
    • Board of Directors
    • Scientific Board
    • Senior Leadership Team
    • Regulation & Quality
    • Press Releases
    • Events & News
  • Products
    • Lung Cancer Blood Test
    • Liver Cancer Blood Test
    • SeroTag® Platform
    • NavigAID
  • Resources
    • Industry Publications
    • Oncimmune Resources
    • Videos
  • Investors
    • Corporate Governance
    • Regulatory Newsflow
    • Share Price and Tools
    • Shareholder Analysis
    • Results, Reports & Presentations
    • Corporate Documents
    • Investor & Advisor Contacts
    • Aim Rule 26
  • Contact Us

Early Cancer Detection Insights

November 04, 2019

Notice of AGM and Annual Report

Read More
November 04, 2019

Draw down of second €3.5 million tranche of credit facility

Read More
November 01, 2019

Oncimmune and Biodesix, Inc. Commence Commercialisation of EarlyCDT® Lung in the Strategic US Market

Read More
October 31, 2019

Full Year Results

Read More
October 25, 2019

Notice of Final Results

Read More
September 23, 2019

Oncimmune makes key appointments to further strengthen management teams

Read More
September 20, 2019

€8.5m credit facility secured

Read More
September 18, 2019

Oncimmune to Present at 2019 China BioMed Innovation and Investment Conference in Suzhou, China

Read More
September 09, 2019

Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer

Read More
oncimmune

Clinical Sciences Building
Hucknall Road
Nottingham NG5 1PB
UNITED KINGDOM

Ph: +44 115 8231869

2nd Floor
51 Eastcheap
London EC3M 1JP
UNITED KINGDOM

Terms & Conditions Privacy Policy Cookies
twitter facebook linkedin